We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-3.31%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$18.5B
AUM Growth
+$95.7M
Cap. Flow
+$1.16B
Cap. Flow %
6.27%
Top 10 Hldgs %
26.36%
Holding
2,855
New
45
Increased
464
Reduced
2,118
Closed
74

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$33.8M
2
AAPL icon
Apple
AAPL
+$29.5M
3
NVDA icon
NVIDIA
NVDA
+$27.4M
4
MSFT icon
Microsoft
MSFT
+$26.2M
5
META icon
Meta Platforms (Facebook)
META
+$17.4M

Sector Composition

Rank Sector Weight
1 Technology 26.11%
2 Financials 14.21%
3 Healthcare 11%
4 Consumer Discretionary 10.49%
5 Industrials 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UP icon
2826
Wheels Up
UP
$185M
-1,434
Closed -$47.3K
VTYX
2827
DELISTED
Ventyx Biosciences
VTYX
-26,731
Closed -$58.5K
ZNTL icon
2828
Zentalis Pharmaceuticals
ZNTL
$307M
-22,971
Closed -$69.6K
CTNM
2829
Contineum Therapeutics
CTNM
$592M
-7,029
Closed -$103K
ARTV
2830
Artiva Biotherapeutics
ARTV
$555M
-8,733
Closed -$88K
MBX
2831
MBX Biosciences
MBX
$3.22B
-7,230
Closed -$133K
SEPN
2832
Septerna Inc
SEPN
$2.16B
-11,555
Closed -$265K
ALTR
2833
DELISTED
Altair Engineering Inc
ALTR
-65,227
Closed -$7.12M
AZPN
2834
DELISTED
Aspen Technology Inc
AZPN
-14,981
Closed -$3.74M
INFN
2835
DELISTED
Infinera Corporation Common Stock
INFN
-118,124
Closed -$776K
CFB
2836
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
-27,711
Closed -$420K
PFC
2837
DELISTED
Premier Financial Corp. Common Stock
PFC
-21,310
Closed -$545K
MTTR
2838
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
-157,714
Closed -$748K
HCP
2839
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
-7,555
Closed -$258K
NARI
2840
DELISTED
Inari Medical, Inc. Common Stock
NARI
-32,094
Closed -$1.64M
ZUO
2841
DELISTED
Zuora, Inc.
ZUO
-82,012
Closed -$814K
CTV
2842
DELISTED
Innovid Corp.
CTV
-67,977
Closed -$210K
ROIC
2843
DELISTED
Retail Opportunity Investments Corp.
ROIC
-78,662
Closed -$1.37M
SUM
2844
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-72,948
Closed -$3.69M
RVNC
2845
DELISTED
Revance Therapeutics, Inc.
RVNC
-60,514
Closed -$184K
CDMO
2846
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
-38,018
Closed -$470K
HTLF
2847
DELISTED
Heartland Financial USA, Inc.
HTLF
-25,747
Closed -$1.58M
B
2848
DELISTED
Barnes Group Inc.
B
-28,130
Closed -$1.33M
SMAR
2849
DELISTED
Smartsheet Inc.
SMAR
-8,353
Closed -$468K
USAP
2850
DELISTED
Universal Stainless & Alloy
USAP
-5,098
Closed -$224K

Similar funds

MetLife Investment Management's Q1 2025 Portfolio in Review

As of Q1 2025, MetLife Investment Management held 2,855 positions worth $18.5B, up 0.52% from $18.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

MetLife Investment Management deployed $1.16B of net new capital in Q1 2025, opening 45 new positions and adding to 464 existing holdings. Its largest new stake was Stevanato: 633,887 shares worth $12.9M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $33.8M trimmed.

  • MetLife Investment Management's largest Q1 2025 buy was Stevanato: 633,887 shares worth $12.9M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $179M increase.
  • MetLife Investment Management's biggest Q1 2025 reduction was iShares MSCI EAFE ETF, cutting an estimated $33.8M.
  • MetLife Investment Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $7.12M.
  • MetLife Investment Management's ten largest holdings make up 26% of its $18.5B portfolio in Q1 2025.
  • MetLife Investment Management opened 45 new positions and closed 74 in Q1 2025.
  • MetLife Investment Management's portfolio value rose 0.52% quarter-over-quarter to $18.5B.

Based on MetLife Investment Management's 13F filing for Q1 2025, filed 14 May 2025.